PORTLAND, Maine, July 11, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Change in Timing of Anticipated FDA Submission
PORTLAND, Maine, June 28, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
PORTLAND, Maine, June 21, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility
PORTLAND, Maine, June 15, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 16, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023
PORTLAND, Maine, May 11, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
Conference Call Scheduled for Friday, May 12, 2023 at 9:00 AM ETPORTLAND, Maine, May 04, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
PORTLAND, Maine, April 05, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022
PORTLAND, Maine, Feb. 21, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
Conference Call Scheduled for Wednesday, February 22, 2023 at 9:00 AM ETPORTLAND, Maine, Feb. 15, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022
PORTLAND, Maine, Jan. 09, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
PORTLAND, Maine, Nov. 21, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
Conference Call Scheduled for Tuesday, November 22, 2022 at 9:00 AM ETPORTLAND, Maine, Nov. 10, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
PORTLAND, Maine, Sept. 14, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022
PORTLAND, Maine, Aug. 11, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ETPORTLAND, Maine, Aug. 04, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
PORTLAND, Maine, July 27, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
PORTLAND, Maine, July 07, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 19, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
Q1 2022 Product Sales Increased 46% over Q1 2021PORTLAND, Maine, May 12, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ETPORTLAND, Maine, May 10, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
UPDATE — Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
PORTLAND, Maine, May 05, 2022 -- Certain immaterial corrections have been made to the second and fifth paragraphs. ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets...
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
PORTLAND, Maine, May 05, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
PORTLAND, Maine, April 11, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
Annual Product Sales for 2021 Increased 25% over 2020PORTLAND, Maine, Feb. 22, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical...
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ETPORTLAND, Maine, Feb. 16, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021
PORTLAND, Maine, Jan. 05, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021
Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000)PORTLAND, Maine, Nov. 15, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021
Conference Call Scheduled for Tuesday, November 16, 2021 at 9:00 AM ETPORTLAND, Maine, Nov. 09, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021
PORTLAND, Maine, Oct. 06, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team
PORTLAND, Maine, Sept. 14, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
PORTLAND, Maine, Aug. 24, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000)PORTLAND, Maine, Aug. 12, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021
Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ETPORTLAND, Maine, Aug. 05, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021
PORTLAND, Maine, July 07, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 19, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021
PORTLAND, Maine, May 13, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021
Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ETPORTLAND, Maine, May 06, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Closes $4,250,000 Equity Financing
PORTLAND, Maine, April 14, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021
PORTLAND, Maine, April 07, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020
PORTLAND, Maine , Feb. 22, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020
Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ETPORTLAND, Maine, Feb. 16, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and...
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020
PORTLAND, Maine, Jan. 07, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Restructuring of its Bank Debt
PORTLAND, Maine, Dec. 15, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020
PORTLAND, Maine, Nov. 12, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020
Conference Call Scheduled for Friday, November 13, 2020 at 9:00 AM ETPORTLAND, Maine, Nov. 05, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020
PORTLAND, Maine, Oct. 06, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020
PORTLAND, Maine, Aug. 12, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020
PORTLAND, Maine, July 07, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
